Common Contracts
4 similar Voting and Support Agreement contracts by Biogen Inc., Reata Pharmaceuticals Inc
VOTING AND SUPPORT AGREEMENTVoting and Support Agreement • July 31st, 2023 • Reata Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
THIS VOTING AND SUPPORT AGREEMENT is dated as of July 28, 2023 (this “Agreement”), by and among each stockholder of Reata Pharmaceuticals, Inc., a Delaware corporation (the “Company”), set forth on Exhibit A hereto (each a “Holder” and collectively the “Holders”), Biogen Inc., a Delaware corporation (“Parent”), and River Acquisition, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (“Merger Sub”).
VOTING AND SUPPORT AGREEMENTVoting and Support Agreement • July 31st, 2023 • Biogen Inc. • Biological products, (no disgnostic substances) • Delaware
THIS VOTING AND SUPPORT AGREEMENT is dated as of July 28, 2023 (this “Agreement”), by and among each stockholder of Reata Pharmaceuticals, Inc., a Delaware corporation (the “Company”), set forth on Exhibit A hereto (each a “Holder” and collectively the “Holders”), Biogen Inc., a Delaware corporation (“Parent”), and River Acquisition, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (“Merger Sub”).
VOTING AND SUPPORT AGREEMENTVoting and Support Agreement • July 31st, 2023 • Reata Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
THIS VOTING AND SUPPORT AGREEMENT is dated as of July 28, 2023 (this “Agreement”), by and among each stockholder of Reata Pharmaceuticals, Inc., a Delaware corporation (the “Company”), set forth on Exhibit A hereto (each a “Holder” and collectively the “Holders”), Biogen Inc., a Delaware corporation (“Parent”), and River Acquisition, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (“Merger Sub”).
VOTING AND SUPPORT AGREEMENTVoting and Support Agreement • July 31st, 2023 • Biogen Inc. • Biological products, (no disgnostic substances) • Delaware
THIS VOTING AND SUPPORT AGREEMENT is dated as of July 28, 2023 (this “Agreement”), by and among each stockholder of Reata Pharmaceuticals, Inc., a Delaware corporation (the “Company”), set forth on Exhibit A hereto (each a “Holder” and collectively the “Holders”), Biogen Inc., a Delaware corporation (“Parent”), and River Acquisition, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (“Merger Sub”).
